..."and there's plenty of experimental evidence for beneficial effects of ABL on heart muscle to back it up. There are 6 million people in the USA alone with heart failure, who need daily lifelong therapy."

Thank you for your insights...always appreciated

Do you see a possibilty of Apabetalone being effective for those afflicted with this who are not T2D?  I know I'm a bit of a pain - banging on  about "with or without T2D" - it would probably take more expensive P3 trials to get approval beyond T2D.  And your statement on the beneficial effects on the heart muscle makes me wonder about COVID patients who have suffered heart damage receiving Apabetalone as a therapeutic.